![Foto de ISABEL](/img/uploaded/AB201CC0FE473161E707556A224E36EC.jpg)
ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada de Ciencias de la Salud
Publications (128) ISABEL CASTREJÓN FERNÁNDEZ publications
2024
-
Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register
Seminars in Arthritis and Rheumatism, Vol. 64
-
Early identification of golimumab-treated patients with higher likelihood of long-term retention
Frontiers in Immunology, Vol. 15
-
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Real-world data from the BIOBADASER registry
Annals of the Rheumatic Diseases
-
Macrophage re-programming by JAK inhibitors relies on MAFB
Cellular and Molecular Life Sciences, Vol. 81, Núm. 1
-
Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center
BMC Musculoskeletal Disorders, Vol. 25, Núm. 1
-
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
Seminars in Arthritis and Rheumatism, Vol. 65
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
-
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598
-
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
Reumatologia Clinica
2023
-
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry (Arthritis Research & Therapy, (2023), 25, 1, (86), 10.1186/s13075-023-03045-3)
Arthritis Research and Therapy
-
Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: A monocentric survey'
Annals of the Rheumatic Diseases
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry
Arthritis Care and Research, Vol. 75, Núm. 1, pp. 115-124
-
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
Advances in Rheumatology, Vol. 63, Núm. 1
-
Gender biases in Spanish rheumatology: Perception and facts
Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401